top of page

New Managed Access programme for isavuconazole

Clinigen and Basilea have initiated a Managed Access programme for isavuconazole to treat patients with invasive fungal infections in those European countries where the therapy has been approved but is not yet commercially available.


Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/41613/news/industry-news/isavuconazole-managed-access-programme/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page